Frequency and Correlates of Co-Infection Hepatitis C and Hepatitis B with HIV
DOI:
https://doi.org/10.22100/jkh.v6i3.106Keywords:
Frequency, Co infection, Viral hepatitis, HIV.Abstract
Introduction: Two of the most critical co-infection associated in patients with HIV is hepatitis C and hepatitis B. Thus considering the adverse effects of these co-infections and the paucity of research in this area, this study was conducted to describe the frequency of co-infection hepatitis B and hepatitis C in patients with HIV and the related factors.
Methods: Three hundred and sixty five infected patients from the voluntary counselling and testing center of Imam Khomeini Hospital in Tehran, Iran participated in this cross sectional study. The individuals who co-infected with hepatitis B, C and also HIV were selected. Then the information like demographic factors, routes of transmission, history of vaccination, stage of disease and HBs Ab were extracted from their records.
Results: Our results showed that 26.3% of patients were co-infected with HIV / HBV/ HCV. One hundred and eighty eight infected patients (51.5%) were between 21 to 40 years. Out of all co-infected patients 34.9% were infected through drug injection. Moreover 30.1% of them were in incubation stage of disease. Furthermore, 22.3% of patients with co-infection had the positive history of Hepatitis B vaccination and 30.7% of all co-infected participants revealed HBs Ab positive.
Conclusion: We recommend that HIV positive patients should inject hepatitis B vaccine. Also, it is emphasized to take Highly Active Antiretroviral Therapy (HAART) in patients suffering from co-infection with HIV, HBV and HCV.
References
Carpenter CJC, Flanigan TP, Lederman MM. HIV infection and the acquired immunodeficiency syndrome. In: Cecil Essentials of medicine. 5th ed. U.S.A: W.B. Saunders Company; 2001.p.841-53.
Fauci AS, Clifford Lane H. Immunodeficiency virus disease: aids and related disorders. 16th ed. U.S.A: the McGraw-Hill Companies; 2005.p.1114-15.
Albrecht H. Report from the 14th Retrovirus Conference. New data on HIV and viral hepatitis coinfection. AIDS Clin Care 2007;19 (5):41.
Gouya MM. National Report on HIV and AIDS Cases. Tehran, Iran: Disease Management Center, Ministry of Health and Medical Education, 2009.
Hosseini M, SeyedAlinaghi S, Kheirandish P, Esmaeli Javid G, Shirzad H, Karami N, et al. Prevalence and correlates of co-infection with human immunodeficiency virus and hepatitis C virus in male injection drug users in Iran. Arch Iran Med 2010;13:318-23.
Koziel MJ, Peters MG. Viral Hepatitis in HIV infection. N Engl J Med 2007:356(14); 1445-1454.
SeyedAlinaghi S, Jam S, Mehrkhani F, Fattahi F, Sabzvari D, Kourorian Z, et al. Hepatitis-C and hepatitis-B co-infections in patients with human immunodeficiency virus in Tehran, Iran. Acta Med Iran 2011;49(4):252-7.
Alter MJ. Epidemiology of viral hepatitis and HIV confection. J Hepatol 2006; 44(1 Suppl): S6-9.
Adewole OO, Anteyi E, Ajuwon Z, Wada I, Elegba F, Ahmed P, et al. Hepatitis B and C virus co-infection in nigerian patients with HIV infection. J Infect Dev Ctries 2009 1;3(5):369-75.
Muralidhar S, Bala M, Jain RK , Malhotra M, Ray K. Hepatitis B and C Positivity in various categories of human immunodeficiency virus seropositive individuals in a regional std centre-an eight-year evaluation of trends and risk factors. American Medical Journal 2010:1(2);103-108.
Saravanan S, Velu V, Kumarasamy N, Nandakumar S, Murugavel KG, Balakrishnan P, et al. Coinfection of hepatitis B and hepatitis C virus in HIV-infected patients in south India. World J Gastroenterol 2007;13:5015-20.
de Almeida Pereira RA, Mussi AD, de Azevedo e Silva VC, Souto FJ. Hepatitis B virus infection in HIV-positive population in Brazil: results of a survey in the state of mato Grosso and a comparative analysis with other regions of Brazil. BMC Infection Diseases 2006;6:34.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
